secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2026-08-21T20:05:15+00:00
Accession:  0001193125-26-361085
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VivoSim gets Nasdaq delisting notice for bid price; proposes 1:5-1:20 reverse split
--------------------------------------------------------------------------------

- Nasdaq notice on Aug 17, 2026: VIVS closing bid below $1 for 30 consecutive sessions.
- Company has 180 days, to Feb 16, 2027, to regain $1+ bid for 10 straight days.
- If not cured, may get 180-day extension if it meets other Nasdaq Capital Market standards.
- Board proposes reverse stock split of 1-for-5 to 1-for-20, subject to stockholder approval at 2026 annual meeting.
- Stock continues trading on Nasdaq as VIVS; delisting risk if compliance not regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000119312526361085/0001193125-26-361085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000119312526361085/vivs-20260817.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-361085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer